FY2024 EPS Estimates for Integer Increased by Zacks Research

Integer Holdings Co. (NYSE:ITGR) – Research analysts at Zacks Research raised their FY2024 earnings per share estimates for Integer in a note issued to investors on Tuesday, January 7th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings per share of $5.33 for the year, up from their prior estimate of $5.32. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q1 2025 earnings at $1.32 EPS, Q4 2025 earnings at $1.67 EPS, Q2 2026 earnings at $1.55 EPS and Q4 2026 earnings at $1.76 EPS.

A number of other equities research analysts also recently weighed in on the stock. KeyCorp lifted their price target on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a research note on Friday, October 25th. Citigroup raised their target price on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Bank of America increased their price target on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Finally, Truist Financial increased their target price on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Integer presently has a consensus rating of “Moderate Buy” and a consensus target price of $145.44.

Integer Stock Performance

ITGR opened at $133.13 on Thursday. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock has a market cap of $4.47 billion, a price-to-earnings ratio of 41.09, a PEG ratio of 1.99 and a beta of 1.12. Integer has a 12-month low of $94.56 and a 12-month high of $142.76. The business has a 50 day moving average of $135.55 and a 200-day moving average of $127.68.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.27 EPS.

Institutional Investors Weigh In On Integer

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Contravisory Investment Management Inc. increased its position in Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 80 shares in the last quarter. Huntington National Bank increased its stake in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 268 shares in the last quarter. Quest Partners LLC grew its holdings in shares of Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the last quarter. Versant Capital Management Inc increased its position in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after acquiring an additional 183 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Integer by 74.1% in the 3rd quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 278 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.